Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Rimonabant for Walking Ability in Chronic Stroke
NCT07913763Phase 2Not yet recruiting
- Sponsor
- Sinfatin
- Start
- Nov 2026
- Primary completion
- Jan 2028
- Countries
- 1
01
Overview
A Phase 2 trial of rimonabant in stroke, sponsored by Sinfatin. Planned start Nov 2026; status: not yet recruiting.
02
Drugs
rimonabant
03
Conditions
stroke
Beyond the preview
Go deeper on NCT07913763.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07913763.